Navigation Links
Blind patient reads words stimulated directly onto the retina
Date:11/22/2012

For the very first time researchers have streamed braille patterns directly into a blind patient's retina, allowing him to read four-letter words accurately and quickly with an ocular neuroprosthetic device. The device, the Argus II, has been implanted in over 50 patients, many of who can now see color, movement and objects. It uses a small camera mounted on a pair of glasses, a portable processor to translate the signal from the camera into electrical stimulation, and a microchip with electrodes implanted directly on the retina. The study was authored by researchers at Second Sight, the company who developed the device, and has been published in Frontiers in Neuroprosthetics on the 22nd of November.

"In this clinical test with a single blind patient, we bypassed the camera that is the usual input for the implant and directly stimulated the retina. Instead of feeling the braille on the tips of his fingers, the patient could see the patterns we projected and then read individual letters in less than a second with up to 89% accuracy," explains researcher Thomas Lauritzen, lead author of the paper.

Similar in concept to successful cochlear implants, the visual implant uses a grid of 60 electrodesattached to the retinato stimulate patterns directly onto the nerve cells. For this study, the researchers at Second Sight used a computer to stimulate six of these points on the grid to project the braille letters. A series of tests were conducted with single letters as well as words ranging in length from two letters up to four. The patient was shown each letter for half a second and had up to 80% accuracy for short words.

"There was no input except the electrode stimulation and the patient recognized the braille letters easily. This proves that the patient has good spatial resolution because he could easily distinguish between signals on different, individual electrodes." says Lauritzen.

According to Silvestro Micera at EP
'/>"/>

Contact: Thomas Lauritzen, Ph.D.
tlauritzen@2-sight.com
818-833-4105
Frontiers
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Cells from skin create model of blinding eye disease
2. Singapore scientists find genes associated with glaucoma, a major cause of eye blindness
3. New cause of child blindness identified
4. Massachusetts Eye and Ear researchers discover elusive gene that causes a form of blindness from birth
5. Antioxidant shown to reduce blindness risk in extremely premature babies
6. Stem cell scientists discover potential way to expand cells for use with patients
7. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
8. Bergen-Belsen lessons underline vital role that nurses can play in patient feeding
9. INTEGRIS Health Puts Patient Safety in the Palm of Your Hand
10. Society of Interventional Radiology hails affirmation of specialtys role in patient care
11. Predicting how patients respond to therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blind patient reads words stimulated directly onto the retina
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 ... fraud case conviction losses. This figure accounts for a ... according to The Nilson Report, exceeds $11 billion globally. ... tool after a crime has occurred. Investor Mark ... polygraph expert Joe Paolella partnered to administer ...
(Date:3/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces its biometric payment ... products featured in 2015 "I Want That" International CES ... on the DIY Network.   DIY,s "I ... , site of the 2015 International CES for a ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... This release is available in German . ... channels and ion pumps, and thus specifically control them with ... J. Zlch Prize 2012 to four scientists who initiated and ... optogenetics: Ernst Bamberg of the Max Planck Institute of Biophysics ...
... lot of all the hens in the flock, but the ... sperm - and thus more chicks. This sounds natural, but ... of years, people have tinkered with the development of domestic ... large muscle mass and increased egg-laying, we have at the ...
... autism researchers in the University of North Carolina School of ... latest round of funding from the National Institutes of Health,s ... was ranked No. 2 among the top 25 institutions in ... Autism Coordinating Committee, is one of only two institutions that ...
Cached Biology News:Zülch Prize 2012 for founders of optogenetics 2Zülch Prize 2012 for founders of optogenetics 3Zülch Prize 2012 for founders of optogenetics 4For the rooster, size matters 22 UNC faculty receive Autism Centers of Excellence grants for new research 22 UNC faculty receive Autism Centers of Excellence grants for new research 3
(Date:5/5/2015)... 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) ... the three months ended March 31, 2015 and provided ... in Canadian dollars. Effective July 17, ... May 31 to December 31. As a result of ... for the three months ended March 31, 2015, while ...
(Date:5/5/2015)... VetStem Biopharma, proudly announces former ... Schaffer, DVM, as Director of Veterinary Professional Services. ... experience in the veterinary regenerative medicine field Dr ... veterinarian lead organization”. Dr. Alexis Nahama, President ... be responsible for all technical activities in relationship ...
(Date:5/5/2015)... MILFORD, Mass. , May 5, 2015 ... a strategic alliance which offers a first-of-its-kind platform that ... patient access to lab results, transforms the way patients ... Luminate Health provides a HIPAA-compliant ... patients to access, manage, and understand their lab results, ...
(Date:5/5/2015)... DIEGO , May 5, 2015  Renova™ ... for congestive heart failure and other chronic diseases, ... an independent analysis designed to reflect the healthcare ... time. This model will be used to characterize ... CHF, could have on those groups of patients ...
Breaking Biology Technology:Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 2Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 3RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3
... 3, 2011  Generex Biotechnology Corporation ( www.generex.com ) (OTCBB: ... to the early diagnosis, and possibly treatment of, Type ... Class II Epitope Hybrids Derived from Proinsulin and GAD ... appears in the April issue of the international peer-reviewed ...
... SAN DIEGO, May 3, 2011 Verenium Corporation (NASDAQ: ... and commercialization of high-performance industrial enzyme solutions, today announced ... 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing. ... the Toronto Convention Center.   James Levine, ...
... VIEW, Calif., May 3, 2011 MAP Pharmaceuticals, Inc. (Nasdaq: ... first quarter ended March 31, 2011. The net ... $17.6 million compared to a net loss of $14.1 million ... first quarter ended March 31, 2011 was related primarily to ...
Cached Biology Technology:Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes 2Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes 3Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes 4Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing 2Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing 3MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 2MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 3MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 4MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results 5
... The pYD1 Yeast Display Vector is specifically ... on the surface of Saccharomyces cerevisiae. Displayed ... to interact with known or putative ligands. ... which consists of two domains Aga1 and ...
Packaging: 6 bottles for 1 l ready-to-use-solution ID clarifier: ready-to-use solution ...
... Polyclonal Antibody against Aph-1a (Aph-1aL,S ... The gamma secretase is a multiprotein ... and Pen-2; all four proteins are ... gamma secretase complex catalyzes cleavage of ...
... Bio-Beads S-X media are ... for size exclusion chromatography of ... that require organic eluents. The ... toluene, xylene, carbon tetrachloride, dimethylformamide, ...
Biology Products: